Children's Health Defense and five plaintiffs filed a lawsuit against the American Academy of Pediatrics in January 2026, accusing it of racketeering related to vaccine safety claims. The case is complicated by lead plaintiff Andrea Shaw's indictment for the murder of her twins, which she claims were vaccine-related. The AAP seeks dismissal of the lawsuit.

President Trump signed Executive Order 14420 on August 10, advocating for vaccinations against 11 diseases for children. It directs agencies to promote these recommendations without altering the CDC's current immunization schedule. The order has faced opposition from medical groups, and court challenges to previous CDC changes remain unresolved.

On August 7, 2026, OpenAI announced a pause in activities related to its Astra model after internal evaluations indicated strong cyber capabilities that could potentially reach a critical risk tier. The company is implementing stricter security measures for higher-capability models to enhance safety during development, as it continues to assess Astra.

Laronix, a Brisbane-based medical technology firm, is testing its MIRA-AI feature that recreates patients' voices using just 10 seconds of audio, with plans for a wider release next year. Their existing product, AVA Voice, is a wearable artificial larynx already in use across over 40 hospitals in Australia and the U.S.

Buc-ee's filed a trademark lawsuit against Beaver's Mini Mart in Ohio on July 28, following John Oliver's call for legal action against a comparable company. Buc-ee's, which operates multiple locations and generates substantial revenue primarily from merchandise, is accused of using scarcity as a business strategy while facing backlash for suing a small, local competitor.

President Trump signed Executive Order 14420 on August 10, advocating for vaccinations against 11 diseases for children. It directs agencies to promote these recommendations without altering the CDC's current immunization schedule. The order has faced opposition from medical groups, and court challenges to previous CDC changes remain unresolved.

On August 7, 2026, OpenAI announced a pause in activities related to its Astra model after internal evaluations indicated strong cyber capabilities that could potentially reach a critical risk tier. The company is implementing stricter security measures for higher-capability models to enhance safety during development, as it continues to assess Astra.

Laronix, a Brisbane-based medical technology firm, is testing its MIRA-AI feature that recreates patients' voices using just 10 seconds of audio, with plans for a wider release next year. Their existing product, AVA Voice, is a wearable artificial larynx already in use across over 40 hospitals in Australia and the U.S.